Alzheimer’s disease. Stroke. ALS. Parkinson’s disease. Today, more than 10 million people in the U.S. suffer from cognitive and physical impairment as a result of these and other neurodegenerative diseases. By 2030, when 1 in 5 Americans will be over the age of 65, these numbers are expected to more than double. Unfortunately, there has been very little progress to date in the early diagnosis and discovery of effective treatments for neurodegenerative diseases.
Through pioneering research by AZTherapies’ founders and other renowned scientists, it is becoming increasingly clear that neuroinflammation plays a critical role in neuronal death in the brain and spinal column, resulting in cognitive and motor function impairment. AZTherapies is a pioneer in neurodegenerative therapeutics by exploring the importance of the immune system in disease development.
